Literature DB >> 14648456

Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.

L De La Fuente1, M J Bravo, G Barrio, F Parras, M Suárez, A Rodés, I Noguer.   

Abstract

In Spain, approximately 10 years passed between the time when human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) harm-reduction programs should have been developed with sufficient coverage to have an optimum impact on public health (before the HIV/AIDS epidemic's explosion in 1984) and the date of their actual implementation. This delay yielded an enormous cost for the country. The introduction of the virus in drug injector networks during a period of widespread diffusion of heroin injection and the lack of political awareness of the growing problem were 2 important factors that contributed to the important diffusion of the HIV infection among Spanish injection drug users. Lessons can be learned that may be of great interest in countries or territories facing similar challenges now and in the future.

Entities:  

Mesh:

Year:  2003        PMID: 14648456     DOI: 10.1086/377562

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Trends in HIV testing, serial HIV prevalence and HIV incidence among people attending a Center for AIDS Prevention from 1988 to 2003.

Authors:  I Hurtado; I Alastrue; I Ferreros; J del Amo; C Santos; T Tasa; I Hernández-Aguado; S Pérez-Hoyos
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

2.  Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

Authors:  Luis de la Fuente; María José Bravo; Carlos Toro; M Teresa Brugal; Gregorio Barrio; Vicente Soriano; Fernando Vallejo; Rosario Ballesta
Journal:  J Epidemiol Community Health       Date:  2006-06       Impact factor: 3.710

3.  Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.

Authors:  G Barrio; L De La Fuente; C Toro; T M Brugal; V Soriano; F Gonzalez; M J Bravo; F Vallejo; T C Silva
Journal:  Epidemiol Infect       Date:  2006-09-28       Impact factor: 2.451

4.  Differences between women and men in serial HIV prevalence and incidence trends.

Authors:  Isabel Hurtado Navarro; I Alastrue; J Del Amo; C Santos; I Ferreros; T Tasa; S Pérez-Hoyos
Journal:  Eur J Epidemiol       Date:  2008-04-11       Impact factor: 8.082

5.  Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Authors:  Marta Torrens; Francina Fonseca; Claudio Castillo; Antonia Domingo-Salvany
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

Review 6.  AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.

Authors:  Vicente Soriano; José M Ramos; Pablo Barreiro; Jose V Fernandez-Montero
Journal:  Viruses       Date:  2018-05-30       Impact factor: 5.048

7.  Distributing foil from needle and syringe programmes (NSPs) to promote transitions from heroin injecting to chasing: an evaluation.

Authors:  Rachael Pizzey; Neil Hunt
Journal:  Harm Reduct J       Date:  2008-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.